vs
Side-by-side financial comparison of Hyperscale Data, Inc. (GPUS) and SCYNEXIS INC (SCYX). Click either name above to swap in a different company.
Hyperscale Data, Inc. is the larger business by last-quarter revenue ($26.9M vs $18.6M, roughly 1.4× SCYNEXIS INC). SCYNEXIS INC runs the higher net margin — 65.7% vs -112.0%, a 177.7% gap on every dollar of revenue. On growth, SCYNEXIS INC posted the faster year-over-year revenue change (1808.5% vs 38.4%). Over the past eight quarters, SCYNEXIS INC's revenue compounded faster (268.5% CAGR vs -16.3%).
Hyperscale Data, Inc. provides GPU-accelerated computing infrastructure and cloud solutions tailored for AI development, big data processing, and high-performance computing workloads. It primarily serves AI startups, large technology firms, and cloud service providers across North America and the Asia-Pacific region, delivering scalable, high-efficiency computing resources to support complex data processing needs.
SCYNEXIS Inc. is a biotechnology company focused on developing innovative antifungal therapies to address unmet medical needs for difficult-to-treat fungal infections. It targets hospital and specialty care markets, with key product candidates serving immunocompromised patients and other high-risk groups.
GPUS vs SCYX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.9M | $18.6M |
| Net Profit | $-30.1M | $12.3M |
| Gross Margin | 14.5% | — |
| Operating Margin | -117.8% | 56.3% |
| Net Margin | -112.0% | 65.7% |
| Revenue YoY | 38.4% | 1808.5% |
| Net Profit YoY | -6670.3% | 376.5% |
| EPS (diluted) | — | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.9M | $18.6M | ||
| Q3 25 | $24.3M | $334.0K | ||
| Q2 25 | $25.9M | $1.4M | ||
| Q1 25 | $25.0M | $257.0K | ||
| Q4 24 | $19.4M | $977.0K | ||
| Q3 24 | $31.1M | $660.0K | ||
| Q2 24 | $17.8M | $736.0K | ||
| Q1 24 | $38.4M | $1.4M |
| Q4 25 | $-30.1M | $12.3M | ||
| Q3 25 | $-13.0M | $-8.6M | ||
| Q2 25 | $-19.1M | $-6.9M | ||
| Q1 25 | $-4.2M | $-5.4M | ||
| Q4 24 | $-445.0K | — | ||
| Q3 24 | $-25.5M | $-2.8M | ||
| Q2 24 | $-33.9M | $-14.5M | ||
| Q1 24 | $3.7M | $411.0K |
| Q4 25 | 14.5% | — | ||
| Q3 25 | 25.8% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 21.1% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 27.5% | — | ||
| Q2 24 | -21.3% | — | ||
| Q1 24 | 47.4% | — |
| Q4 25 | -117.8% | 56.3% | ||
| Q3 25 | -57.8% | -2516.5% | ||
| Q2 25 | -39.2% | -701.0% | ||
| Q1 25 | -25.5% | -3350.2% | ||
| Q4 24 | -46.8% | — | ||
| Q3 24 | -79.2% | -1563.6% | ||
| Q2 24 | -151.4% | -1255.0% | ||
| Q1 24 | 9.5% | -692.5% |
| Q4 25 | -112.0% | 65.7% | ||
| Q3 25 | -53.5% | -2572.2% | ||
| Q2 25 | -73.7% | -504.8% | ||
| Q1 25 | -16.8% | -2097.7% | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | -82.3% | -425.5% | ||
| Q2 24 | -190.7% | -1964.4% | ||
| Q1 24 | 9.7% | 29.9% |
| Q4 25 | — | $0.25 | ||
| Q3 25 | $-0.39 | $-0.17 | ||
| Q2 25 | $-2.66 | $-0.14 | ||
| Q1 25 | — | $-0.11 | ||
| Q4 24 | $-8.78 | — | ||
| Q3 24 | $-24.82 | $-0.06 | ||
| Q2 24 | $-37.81 | $-0.30 | ||
| Q1 24 | $3.32 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.1M | $40.0M |
| Total DebtLower is stronger | $83.1M | — |
| Stockholders' EquityBook value | $119.8M | $49.4M |
| Total Assets | $313.7M | $59.0M |
| Debt / EquityLower = less leverage | 0.69× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.1M | $40.0M | ||
| Q3 25 | $24.8M | $37.9M | ||
| Q2 25 | $5.9M | $44.8M | ||
| Q1 25 | $4.2M | $40.6M | ||
| Q4 24 | $4.5M | $59.3M | ||
| Q3 24 | $7.9M | $68.8M | ||
| Q2 24 | $9.6M | $73.0M | ||
| Q1 24 | $18.9M | $80.2M |
| Q4 25 | $83.1M | — | ||
| Q3 25 | $80.0M | — | ||
| Q2 25 | $88.5M | — | ||
| Q1 25 | $92.8M | — | ||
| Q4 24 | $96.7M | — | ||
| Q3 24 | $104.8M | — | ||
| Q2 24 | $106.8M | — | ||
| Q1 24 | $30.0M | — |
| Q4 25 | $119.8M | $49.4M | ||
| Q3 25 | $55.9M | $36.4M | ||
| Q2 25 | $5.5M | $44.5M | ||
| Q1 25 | $6.3M | $50.5M | ||
| Q4 24 | $8.6M | $55.1M | ||
| Q3 24 | $2.7M | $58.5M | ||
| Q2 24 | $26.7M | $60.4M | ||
| Q1 24 | $59.0M | $74.1M |
| Q4 25 | $313.7M | $59.0M | ||
| Q3 25 | $242.4M | $51.1M | ||
| Q2 25 | $213.5M | $60.7M | ||
| Q1 25 | $218.5M | $67.9M | ||
| Q4 24 | $220.8M | $90.6M | ||
| Q3 24 | $231.5M | $99.0M | ||
| Q2 24 | $270.8M | $107.8M | ||
| Q1 24 | $299.8M | $118.3M |
| Q4 25 | 0.69× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 16.06× | — | ||
| Q1 25 | 14.71× | — | ||
| Q4 24 | 11.19× | — | ||
| Q3 24 | 38.41× | — | ||
| Q2 24 | 4.00× | — | ||
| Q1 24 | 0.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-37.7M | $18.4M |
| Free Cash FlowOCF − Capex | $-56.2M | — |
| FCF MarginFCF / Revenue | -208.7% | — |
| Capex IntensityCapex / Revenue | 68.6% | — |
| Cash ConversionOCF / Net Profit | — | 1.50× |
| TTM Free Cash FlowTrailing 4 quarters | $-87.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-37.7M | $18.4M | ||
| Q3 25 | $-17.8M | $-8.7M | ||
| Q2 25 | $-3.1M | $-7.5M | ||
| Q1 25 | $-4.0M | $-7.5M | ||
| Q4 24 | $-9.2M | $-24.0M | ||
| Q3 24 | $3.7M | $765.0K | ||
| Q2 24 | $-3.7M | $-10.9M | ||
| Q1 24 | $-10.2M | $-4.0M |
| Q4 25 | $-56.2M | — | ||
| Q3 25 | $-20.6M | — | ||
| Q2 25 | $-3.5M | — | ||
| Q1 25 | $-6.8M | — | ||
| Q4 24 | $-9.3M | — | ||
| Q3 24 | $2.6M | — | ||
| Q2 24 | $-5.9M | — | ||
| Q1 24 | $-11.6M | — |
| Q4 25 | -208.7% | — | ||
| Q3 25 | -84.5% | — | ||
| Q2 25 | -13.5% | — | ||
| Q1 25 | -27.3% | — | ||
| Q4 24 | -47.6% | — | ||
| Q3 24 | 8.4% | — | ||
| Q2 24 | -33.4% | — | ||
| Q1 24 | -30.3% | — |
| Q4 25 | 68.6% | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 11.5% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 12.6% | — | ||
| Q1 24 | 3.7% | — |
| Q4 25 | — | 1.50× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.75× | -9.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GPUS
| Transferred Over Time | $10.4M | 39% |
| Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities | $5.8M | 21% |
| Hotel And Real Estate Operations | $4.8M | 18% |
| Other | $4.0M | 15% |
| Turn On Green | $2.0M | 7% |
SCYX
| Glaxosmithkline Intellectual Property | $17.2M | 92% |
| Products | $1.4M | 8% |
